Exact Mass: 364.043

Exact Mass Matches: 364.043

Found 45 metabolites which its exact mass value is equals to given mass value 364.043, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Xanthylic acid

{[(2R,3S,4R,5R)-5-(2,6-dioxo-2,3,6,9-tetrahydro-1H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}phosphonic acid

C10H13N4O9P (364.042)


Xanthylic acid, also known as xmp or (9-D-ribosylxanthine)-5-phosphate, is a member of the class of compounds known as purine ribonucleoside monophosphates. Purine ribonucleoside monophosphates are nucleotides consisting of a purine base linked to a ribose to which one monophosphate group is attached. Xanthylic acid is slightly soluble (in water) and a moderately acidic compound (based on its pKa). Xanthylic acid can be found in a number of food items such as common grape, black-eyed pea, java plum, and wild rice, which makes xanthylic acid a potential biomarker for the consumption of these food products. Xanthylic acid exists in all living species, ranging from bacteria to humans. In humans, xanthylic acid is involved in several metabolic pathways, some of which include azathioprine action pathway, glutamate metabolism, mercaptopurine action pathway, and purine metabolism. Xanthylic acid is also involved in several metabolic disorders, some of which include purine nucleoside phosphorylase deficiency, succinic semialdehyde dehydrogenase deficiency, xanthine dehydrogenase deficiency (xanthinuria), and molybdenum cofactor deficiency. Xanthosine monophosphate is an intermediate in purine metabolism. It is a ribonucleoside monophosphate. It is formed from IMP via the action of IMP dehydrogenase, and it forms GMP via the action of GMP synthaseand is) also, XMP can be released from XTP by enzyme deoxyribonucleoside triphosphate pyrophosphohydrolase containing (d)XTPase activity . Xanthylic acid is an important metabolic intermediate in the Purine Metabolism, and is a product or substrate of the enzymes Inosine monophosphate dehydrogenase (EC 1.1.1.205), Hypoxanthine phosphoribosyltransferase (EC 2.4.2.8), Xanthine phosphoribosyltransferase (EC 2.4.2.22), 5-Ribonucleotide phosphohydrolase (EC 3.1.3.5), Ap4A hydrolase (EC 3.6.1.17), Nucleoside-triphosphate diphosphatase (EC 3.6.1.19), Phosphoribosylamine-glycine ligase (EC 6.3.4.1), and glutamine amidotransferase (EC 6.3.5.2). (KEGG) Xanthylic acid can also be used in quantitative measurements of the Inosine monophosphate dehydrogenase enzyme activities in purine metabolism. This measurement is important for optimal thiopurine therapy for children with acute lymphoblastic leukaemia (ALL). (PMID: 16725387). Acquisition and generation of the data is financially supported in part by CREST/JST. COVID info from COVID-19 Disease Map Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

   

5'-xanthylate(2-)

{[5-(2,6-dihydroxy-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}phosphonic acid

C10H13N4O9P (364.042)


5-xanthylate(2-) is also known as 5-Xanthylate dianion or XMP. 5-xanthylate(2-) is considered to be slightly soluble (in water) and acidic

   
   
   

dehydropicrorhiza acid methyl diester

dehydropicrorhiza acid methyl diester

C16H12O10 (364.043)


   

Antibiotic SS 19508B

Antibiotic SS 19508B

C17H13ClO7 (364.035)


   

2-chloro-3,8-dihydroxy-1,6-dimethyl-11-oxo-11H-dibenzo[b,e][1,4]dioxepine-7-carboxylic acid methyl ester|3-Dechlor-lecideoidin|3-Dechlorolecideoidin|dechlorolecideoidin

2-chloro-3,8-dihydroxy-1,6-dimethyl-11-oxo-11H-dibenzo[b,e][1,4]dioxepine-7-carboxylic acid methyl ester|3-Dechlor-lecideoidin|3-Dechlorolecideoidin|dechlorolecideoidin

C17H13ClO7 (364.035)


   
   

2,4,5-trihydroxy-3-(4,6,7-trihydroxy-3-oxo-1,3-dihydroisobenzofuran-5-yl)-benzoic acid methyl ester

2,4,5-trihydroxy-3-(4,6,7-trihydroxy-3-oxo-1,3-dihydroisobenzofuran-5-yl)-benzoic acid methyl ester

C16H12O10 (364.043)


   

Xanthosine 5-monophosphate

Xanthosine 5-monophosphate

C10H13N4O9P (364.042)


   

Xanthosine-5′-monophosphate disodium salt

Xanthosine-5′-monophosphate disodium salt

C10H13N4O9P (364.042)


   

XANTHOSINE 5'-MONOPHOSPHATE

XANTHOSINE 5'-MONOPHOSPHATE

C10H13N4O9P (364.042)


   

XANTHOSINE-MONOPHOSPHATE

XANTHOSINE-MONOPHOSPHATE

C10H13N4O9P (364.042)


   

Gly-Phe4Cl-OH

(S)-3-(4-chlorophenyl)-2-(3-hydroxy-4-nitrobenzamido)propanoic acid

C16H13ClN2O6 (364.0462)


   

Phe4Cl-Gly-OH

2-(3-((4-chlorobenzyl)oxy)-4-nitrobenzamido)acetic acid

C16H13ClN2O6 (364.0462)


   

Oxipurinol-7-ribonucleotide

Oxipurinol-7-ribonucleotide

C10H13N4O9P (364.042)


   

Benzenesulfonic acid,4-[2-(2-hydroxy-1-naphthalenyl)diazenyl]-3-methyl-, sodium salt (1:1)

Benzenesulfonic acid,4-[2-(2-hydroxy-1-naphthalenyl)diazenyl]-3-methyl-, sodium salt (1:1)

C17H13N2NaO4S (364.0494)


   

5,6-Dichloro-1-ethyl-2-methyl-3-(3-sulfobutyl)benzimidazolium inner salt

5,6-Dichloro-1-ethyl-2-methyl-3-(3-sulfobutyl)benzimidazolium inner salt

C14H18Cl2N2O3S (364.0415)


   

LANTHANUM (III) 2-METHOXYETHOXIDE

LANTHANUM (III) 2-METHOXYETHOXIDE

C9H21LaO6 (364.0402)


   

6-METHYL-5-(4-PHENYL-1,3-THIAZOL-2-YL)-2-(TRIFLUOROMETHYL)NICOTINIC ACID

6-METHYL-5-(4-PHENYL-1,3-THIAZOL-2-YL)-2-(TRIFLUOROMETHYL)NICOTINIC ACID

C17H11F3N2O2S (364.0493)


   

ethyl 7-chloro-6-fluoro-1-(4-fluorophenyl)-4-oxo-1,8-naphthyridine-3-carboxylate

ethyl 7-chloro-6-fluoro-1-(4-fluorophenyl)-4-oxo-1,8-naphthyridine-3-carboxylate

C17H11ClF2N2O3 (364.0426)


   

sodium,5-methyl-2-[(2Z)-2-(2-oxonaphthalen-1-ylidene)hydrazinyl]benzenesulfonate

sodium,5-methyl-2-[(2Z)-2-(2-oxonaphthalen-1-ylidene)hydrazinyl]benzenesulfonate

C17H13N2NaO4S (364.0494)


   

1-(2-chloroethyl)-4-[3-(trifluoromethyl)phenyl]piperazine,dihydrochloride

1-(2-chloroethyl)-4-[3-(trifluoromethyl)phenyl]piperazine,dihydrochloride

C13H18Cl3F3N2 (364.0488)


   

2-bromomethyl-4-trifluoromethylbenzene boronic ester

2-bromomethyl-4-trifluoromethylbenzene boronic ester

C14H17BBrF3O2 (364.0457)


   

tris(cyclopentadienyl)thulium

tris(cyclopentadienyl)thulium

C15H15Tm (364.0516)


   

4-chloro-N-[3-cyano-4-(phenylthio)phenyl]benzamide

4-chloro-N-[3-cyano-4-(phenylthio)phenyl]benzamide

C20H13ClN2OS (364.0437)


   

4-[1-[(3,4-Dichlorophenyl)methylamino]propylidene]-2-(2-furanyl)-5-oxazolone

4-[1-[(3,4-Dichlorophenyl)methylamino]propylidene]-2-(2-furanyl)-5-oxazolone

C17H14Cl2N2O3 (364.0381)


   

(5-Chloro-2-{[(3-Nitrobenzyl)amino]carbonyl}phenoxy)acetic Acid

(5-Chloro-2-{[(3-Nitrobenzyl)amino]carbonyl}phenoxy)acetic Acid

C16H13ClN2O6 (364.0462)


   
   

5-formamido-1-(5-phospho-D-ribosyl)imidazole-4-carboxamide(2-)

5-formamido-1-(5-phospho-D-ribosyl)imidazole-4-carboxamide(2-)

C10H13N4O9P-2 (364.042)


COVID info from COVID-19 Disease Map Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

   

1-(4-Bromophenyl)-3-[2-(2-methoxyphenoxy)ethyl]urea

1-(4-Bromophenyl)-3-[2-(2-methoxyphenoxy)ethyl]urea

C16H17BrN2O3 (364.0422)


   

3-chloro-N-[3-(1-imidazolyl)propyl]-6-nitro-1-benzothiophene-2-carboxamide

3-chloro-N-[3-(1-imidazolyl)propyl]-6-nitro-1-benzothiophene-2-carboxamide

C15H13ClN4O3S (364.0397)


   

4-(4-Bromophenyl)-2-(3,5-dimethyl-1-pyrazolyl)-4-oxobutanoic acid methyl ester

4-(4-Bromophenyl)-2-(3,5-dimethyl-1-pyrazolyl)-4-oxobutanoic acid methyl ester

C16H17BrN2O3 (364.0422)


   

2-[[5-(2-fluoroanilino)-1,3,4-thiadiazol-2-yl]thio]-N-(2-furanylmethyl)acetamide

2-[[5-(2-fluoroanilino)-1,3,4-thiadiazol-2-yl]thio]-N-(2-furanylmethyl)acetamide

C15H13FN4O2S2 (364.0464)


   

N,N-diethyl-2-[(3-thiophen-2-yl-7-isothiazolo[4,5-d]pyrimidinyl)thio]acetamide

N,N-diethyl-2-[(3-thiophen-2-yl-7-isothiazolo[4,5-d]pyrimidinyl)thio]acetamide

C15H16N4OS3 (364.0486)


   

5-xanthylic acid

Xanthosine-5-monophosphate

C10H13N4O9P (364.042)


A purine ribonucleoside 5-monophosphate having xanthine as the nucleobase. COVID info from COVID-19 Disease Map Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

   

5-formamido-1-(5-phospho-D-ribosyl)imidazole-4-carboxamide(2-)

5-formamido-1-(5-phospho-D-ribosyl)imidazole-4-carboxamide(2-)

C10H13N4O9P (364.042)


Dianion of 5-formamido-1-(5-phospho-D-ribosyl)imidazole-4-carboxamide.

   

VPC-70619

VPC-70619

C16H8ClF3N4O (364.0339)


VPC-70619 is a potent, orally active N-Myc inhibitor. VPC-70619 blocks the N-Myc-Max heterocomplex from binding to DNA E-boxes and demonstrated strong inhibition activity against N-Myc-dependent cell lines as well as high bioavailability in both oral and intraperitoneal administration[1].

   

methyl 1,2,3,4,6,7,8-heptahydroxy-10-oxo-9h-anthracene-9-carboxylate

methyl 1,2,3,4,6,7,8-heptahydroxy-10-oxo-9h-anthracene-9-carboxylate

C16H12O10 (364.043)


   

methyl 2,4,5-trihydroxy-3-(4,6,7-trihydroxy-3-oxo-1h-2-benzofuran-5-yl)benzoate

methyl 2,4,5-trihydroxy-3-(4,6,7-trihydroxy-3-oxo-1h-2-benzofuran-5-yl)benzoate

C16H12O10 (364.043)


   

(1,2,3,4,6,7,8-heptahydroxy-10-oxo-9h-anthracen-9-yl)acetic acid

(1,2,3,4,6,7,8-heptahydroxy-10-oxo-9h-anthracen-9-yl)acetic acid

C16H12O10 (364.043)


   

[(9s)-1,2,3,4,6,7,8-heptahydroxy-10-oxo-9h-anthracen-9-yl]acetic acid

[(9s)-1,2,3,4,6,7,8-heptahydroxy-10-oxo-9h-anthracen-9-yl]acetic acid

C16H12O10 (364.043)


   

[(2s,3s,4s,5s)-5-(2,6-dihydroxypurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxyphosphonic acid

[(2s,3s,4s,5s)-5-(2,6-dihydroxypurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxyphosphonic acid

C10H13N4O9P (364.042)


   

poly(xanthylic acid)

poly(xanthylic acid)

C10H13N4O9P (364.042)